GLASSIA 1 g/50mL
ALPHA.1-PROTEINASE INHIBITOR HUMAN · INJECTION, SOLUTION · Takeda Pharmaceuticals America, Inc.
GLASSIA is a injection, solution containing alpha.1-proteinase inhibitor human at 1 g/50mL, taken intravenous. Manufactured by Takeda Pharmaceuticals America, Inc..
Key Facts
- Brand Name
- GLASSIA
- Generic Name
- ALPHA.1-PROTEINASE INHIBITOR HUMAN
- NDC Code (Product)
0944-2884- Manufacturer
- Takeda Pharmaceuticals America, Inc.
- Strength
- 1 g/50mL
- Dosage Form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS
- Marketing Status
- Application #
- BLA125325
- Marketing Start
- 07/01/2010
Recall History
No Recall HistoryFrequently Asked Questions
What is GLASSIA used for?
GLASSIA contains ALPHA.1-PROTEINASE INHIBITOR HUMAN. It is a injection, solution taken intravenous. Consult your doctor for specific uses.
Is GLASSIA a controlled substance?
GLASSIA is not classified as a controlled substance by the DEA.
What is the generic name for GLASSIA?
The generic name for GLASSIA is ALPHA.1-PROTEINASE INHIBITOR HUMAN. There are no other listed brand versions of ALPHA.1-PROTEINASE INHIBITOR HUMAN.
What is the NDC code for GLASSIA 1 g/50mL?
The NDC (National Drug Code) for GLASSIA 1 g/50mL is 0944-2884, listed by Takeda Pharmaceuticals America, Inc..
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)